The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Is BPC 157 Legal? Understanding Its Status and Implications As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco